PIK3R3 and neoplasm: Tumor #1, in addition to the mutations observed in Tumor #2, also harbored mutations in CBL (56.7%), PIKFIVE (21%), PIK3CA (38.2%), and PIK3R3 (25%), (Figure 3A).